GO:0071374 cellular response to parathyroid hormone stimulus: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071374 describes how a single cell changes its state or activity in response to parathyroid hormone (PTH), including movement, secretion, enzyme production and gene expression.
• PTH is the principal peptide regulator of calcium homeostasis, and its cellular effects are mediated largely through the type 1 PTH receptor (PTH1R) on target cells such as osteoblasts and renal tubular cells.
• The cellular response to PTH is dynamically regulated by extracellular calcium and by the calcium-sensing receptor (CaSR), which together set the sensitivity of target cells to PTH.
• Resistance to the renal action of PTH can be reversible in vivo, showing that the cellular response is not a fixed property but can be modulated by physiological state.
• PTH signaling intersects with bone anabolic pathways, including Wnt/LRP5-dependent mechanotransduction, although LRP5 is not required for the anabolic bone response to PTH treatment.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal dissection of genes acting within the cellular response to PTH.
Description
The Gene Ontology term GO:0071374, cellular response to parathyroid hormone stimulus, defines any process that results in a change in state or activity of a cell in terms of movement, secretion, enzyme production, gene expression or other cellular outputs as a result of a parathyroid hormone stimulus. Parathyroid hormone (PTH) is a peptide hormone central to calcium homeostasis, and its actions on target cells are essential for maintaining normal extracellular calcium concentrations. Because the response is cell-autonomous, it is studied at the level of individual target cells such as osteoblasts, osteocytes and renal tubular epithelial cells. At the physiological level, PTH secretion itself is controlled by extracellular calcium, and individual parathyroid cells can respond heterogeneously to calcium changes. This means that the cellular response to PTH must be understood as a tunable process, not a simple on/off switch. The type 1 PTH receptor (PTH1R) is a key mediator, and its conformation can be altered by mechanical stimuli in bone cells, linking PTH responsiveness to the mechanical environment. For researchers, GO:0071374 provides a controlled vocabulary to annotate genes and pathways that mediate PTH-dependent cellular changes. It is relevant to bone biology, mineral metabolism, renal physiology and to therapeutic areas such as osteoporosis, where PTH analogs and bisphosphonates interact. Understanding the cellular response to PTH also helps interpret resistance states in which target cells fail to respond appropriately to the hormone.
cellular response to parathyroid hormone stimulus At A Glance
| GO ID | GO:0071374 |
|---|---|
| GO term | cellular response to parathyroid hormone stimulus |
| Ontology | biological_process |
| Synonym | none |
| Major function | Mediates cell-autonomous changes in state or activity in response to parathyroid hormone, including secretion, enzyme production and gene expression |
| Primary ligand | Parathyroid hormone (PTH), a peptide regulator of calcium homeostasis |
| Key receptor | Type 1 parathyroid hormone receptor (PTH1R) |
| Physiological context | Calcium homeostasis and bone mineral metabolism |
| Regulatory input | Extracellular calcium and the calcium-sensing receptor (CaSR) |
What Is GO:0071374?
In practical terms, GO:0071374 covers the set of intracellular events triggered when a cell encounters parathyroid hormone. The QuickGO definition states that it is any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a parathyroid hormone stimulus. This includes receptor binding at the cell surface, downstream signal transduction, changes in gene expression, and altered secretion or enzyme activity. The term is a biological process and is used to annotate gene products that participate in these PTH-dependent cellular changes.
Why Is cellular response to parathyroid hormone stimulus Important in Cell Biology?
GO:0071374 is important because it captures the cell-level mechanisms through which parathyroid hormone controls calcium homeostasis, bone remodeling and renal handling of minerals. Dysregulation of this response contributes to disorders of calcium balance, and resistance to PTH action has been documented in human physiology. Because the response is modulated by extracellular calcium and by the calcium-sensing receptor, it sits at the intersection of endocrine, renal and skeletal biology. Studying this term helps researchers interpret how genetic variants or pharmacological agents alter PTH responsiveness at the cellular level.
• Defines the cell-autonomous actions of PTH, the master regulator of calcium homeostasis.
• Provides a framework for annotating genes that mediate PTH-dependent secretion, enzyme production and gene expression.
• Links endocrine control of calcium to bone-forming cell activity and skeletal mechanotransduction.
• Explains how extracellular calcium and CaSR tune the sensitivity of target cells to PTH.
• Underpins understanding of reversible resistance to the renal action of PTH in humans.
• Relevant to osteoporosis therapy, where PTH interacts with bisphosphonate treatment.
• Supports research on parathyroid adenoma and heterogeneous parathyroid cell responses.
• Guides CRISPR-based causal testing of candidate genes in PTH-responsive cell types.
• Helps interpret mineral metabolism phenotypes in renal and skeletal disease models.
• Enables cross-species comparison of PTH secretory dynamics and target-cell responses.
What Happens During cellular response to parathyroid hormone stimulus?
PTH secretion and availability
In simple terms: The body first decides how much parathyroid hormone to release into the blood.
The cellular response to PTH begins with the availability of the hormone itself. Parathyroid cells secrete PTH in response to changes in extracellular calcium concentration, and this secretory dynamics has been characterized in normal primate and adenomatous human tissue. Individual parathyroid cells can respond heterogeneously to calcium, meaning that not all cells behave identically at a given calcium level. This heterogeneity shapes the pool of PTH that reaches target cells and therefore the strength of the downstream cellular response.
Receptor engagement at the target cell
In simple terms: PTH docks onto a receptor on the surface of the target cell, like a key in a lock.
Once PTH reaches a target cell, it engages the type 1 parathyroid hormone receptor (PTH1R). Mechanical stimuli can alter the conformation of PTH1R in bone cells, indicating that receptor state is not static and can be influenced by the physical environment. This receptor engagement is the entry point for the cellular response and determines which downstream programs are activated in osteoblasts, osteocytes and renal cells.
Calcium-sensing and set-point modulation
In simple terms: A calcium sensor on the cell helps decide how strongly the cell should react to PTH.
The calcium-sensing receptor (CaSR) provides a mechanism by which extracellular calcium modulates cellular responses, including inflammatory and endocrine signaling. Because PTH secretion and target-cell sensitivity are both calcium-dependent, the CaSR acts as a set-point regulator within the broader physiology of the cellular response to PTH. This helps explain why the same PTH concentration can produce different cellular outcomes depending on the calcium context.
Downstream changes in cell state and activity
In simple terms: After the signal arrives, the cell changes what it makes, releases or does.
The defining output of GO:0071374 is a change in cell state or activity, including movement, secretion, enzyme production and gene expression. In bone, PTH treatment can drive an anabolic response, and this response has been studied in relation to Wnt co-receptor LRP5, which is essential for skeletal mechanotransduction but not for the anabolic bone response to PTH. This dissociation shows that the cellular response to PTH uses pathways that are partly distinct from mechanotransduction.
Reversibility and resistance
In simple terms: The response can be turned down and sometimes turned back up.
The cellular response to PTH is not irreversible. Reversible resistance to the renal action of PTH has been described in humans, demonstrating that target-cell responsiveness can be restored under some conditions. This reversibility is important for interpreting clinical states of PTH resistance and for designing experiments that test whether a gene is required for the response or only modulates its magnitude.
Key Genes Involved in GO:0071374 cellular response to parathyroid hormone stimulus
The following genes and proteins have been experimentally linked to the cellular response to parathyroid hormone stimulus or to its physiological context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTH | Encodes parathyroid hormone, the ligand that initiates the cellular response | Central to calcium homeostasis studies and PTH secretion dynamics |
| PTH1R | Type 1 parathyroid hormone receptor that engages PTH at the target cell surface | Receptor conformation and mechanosensitive signaling in bone cells |
| CASR | Calcium-sensing receptor that modulates cellular responses to calcium and endocrine signals | Set-point regulation of PTH responsiveness and inflammation links |
| LRP5 | Wnt co-receptor essential for skeletal mechanotransduction | Dissociates mechanotransduction from the anabolic bone response to PTH |
| PTHLH | Parathyroid hormone-like hormone, a related ligand in the PTH family | Context for PTH-family signaling in calcium homeostasis |
| GCM2 | Transcription factor implicated in parathyroid development and function | Relevant to heterogeneous parathyroid cell behavior |
| CASR | Calcium-sensing receptor in parathyroid and renal cells | Links extracellular calcium to PTH secretion |
| VDR | Vitamin D receptor, a partner in mineral homeostasis | Context for calcium homeostasis networks |
| FGF23 | Phosphate and vitamin D regulator in mineral metabolism | Cross-talk with PTH-responsive physiology |
| SOST | Sclerostin, a Wnt pathway modulator in bone | Relevant to anabolic bone responses and PTH treatment |
| RUNX2 | Osteoblast transcription factor | Downstream bone-forming programs in PTH-responsive cells |
| SP7 | Osterix, osteoblast differentiation factor | Bone cell state changes after PTH stimulus |
| BGLAP | Osteocalcin, a marker of osteoblast activity | Readout of PTH-driven bone cell activity |
| TNFSF11 | RANKL, regulator of osteoclast biology | Bone remodeling context for PTH and bisphosphonate interactions |
| TNFRSF11B | Osteoprotegerin, decoy receptor in bone remodeling | Bone remodeling context for PTH action |
| CREB1 | Transcription factor downstream of cAMP signaling | Candidate mediator of PTH1R-dependent gene expression |
| PRKACA | Protein kinase A catalytic subunit | Candidate kinase in PTH1R signal transduction |
How Is cellular response to parathyroid hormone stimulus Regulated?
The cellular response to parathyroid hormone stimulus is regulated at multiple levels. Extracellular calcium controls PTH secretion from parathyroid cells, and individual parathyroid cells can respond heterogeneously to calcium. The calcium-sensing receptor (CaSR) provides a molecular sensor that adjusts cellular responses to calcium and endocrine signals. At the target cell, the conformation and activity of PTH1R can be influenced by mechanical stimuli, adding a physical layer of regulation. In bone, the anabolic response to PTH is not dependent on LRP5, indicating that distinct regulatory branches control mechanotransduction and PTH responsiveness. Finally, clinical observations of reversible resistance to the renal action of PTH show that the response can be dynamically downregulated and restored.
cellular response to parathyroid hormone stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTH | Disorders of calcium homeostasis | Knockout or overexpression in parathyroid-like cells |
| PTH1R | Altered target-cell responsiveness to PTH | Point-mutation knock-in of receptor variants |
| CASR | Calcium-sensing and inflammation-related phenotypes | Knockout and tagged knock-in for localization |
| LRP5 | Skeletal mechanotransduction and bone anabolic response | Knockout in osteoblast lineage cells |
| PTHLH | PTH-family ligand biology in mineral metabolism | Overexpression and knockout models |
Disorders of calcium homeostasis
Because PTH is the principal regulator of calcium homeostasis, altered cellular responses to PTH contribute to disorders of calcium balance. Reversible resistance to the renal action of PTH has been documented in humans, showing that target-cell unresponsiveness can be a clinically relevant phenotype. Understanding GO:0071374 helps interpret these states at the cellular level.
Parathyroid adenoma and heterogeneous parathyroid function
Parathyroid adenomas can show altered PTH secretory dynamics, and individual parathyroid cells display heterogeneous responses to calcium. These differences affect how much PTH reaches target cells and therefore how the cellular response is engaged in bone and kidney.
Osteoporosis and bone anabolic therapy
PTH interacts with bisphosphonates in the treatment of skeletal disease, and the anabolic bone response to PTH treatment has been studied in genetic models. LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to PTH, which has implications for understanding how PTH-based therapies work.
Inflammation and the calcium-sensing receptor
The calcium-sensing receptor has been linked to inflammation, providing a connection between calcium-sensing pathways and immune-endocrine crosstalk. This broadens the disease relevance of the cellular response to PTH beyond classical mineral metabolism.
From cellular response to parathyroid hormone stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PTH1R required for the cellular response to PTH? | PTH1R knockout cell model |
| Does a specific PTH1R variant alter downstream signaling? | Point-mutation knock-in of the variant |
| Where is the calcium-sensing receptor localized during PTH response? | Tagged knock-in of CASR |
| Does LRP5 mediate the anabolic bone response to PTH? | LRP5 knockout in bone cells |
| Can overexpression of a candidate gene enhance PTH responsiveness? | Overexpression cell model |
| Which genes are required for PTH-dependent gene expression? | CRISPR library screening in PTH-treated cells |
How to Study the cellular response to parathyroid hormone stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Changes in gene expression after PTH stimulus | Identify PTH-responsive transcriptional programs |
| Receptor conformation assays | State of PTH1R under mechanical or hormonal stimuli | Study mechanosensitive PTH signaling |
| Calcium-sensing assays | CaSR-dependent responses to extracellular calcium | Map set-point regulation of PTH response |
| Secretion assays | Hormone or factor release from target cells | Quantify secretory output of PTH response |
| Enzyme activity assays | Production or activity of PTH-induced enzymes | Measure metabolic outputs of the response |
| CRISPR knockout | Loss-of-function effect on PTH response | Test gene requirement |
| CRISPR knock-in | Effect of specific variants or tags | Model disease-associated alleles |
| Overexpression | Gain-of-function effect on PTH response | Test sufficiency of candidate genes |
Transcriptional profiling of PTH-treated cells
RNA sequencing can measure changes in gene expression that define the cellular response to PTH, since the GO term explicitly includes gene expression as an output. Comparing treated and untreated cells identifies PTH-responsive transcriptional programs in bone and renal cell models.
Receptor conformation and signaling assays
Because mechanical stimuli can alter the conformation of PTH1R in bone cells, assays that report receptor state and downstream signaling are useful for studying the cellular response. These can be combined with calcium-sensing receptor readouts to capture set-point modulation.
Secretion and enzyme production measurements
The GO definition includes secretion and enzyme production as cellular outputs. Assays that quantify secreted factors or enzyme activity in PTH-treated cells provide direct functional readouts of the response.
Genetic perturbation with CRISPR
CRISPR knockout, point mutation, knock-in and overexpression allow causal testing of genes implicated in the cellular response to PTH. These approaches help distinguish genes required for the response from those that merely correlate with it.
How CRISPR Can Be Used to Study GO:0071374 cellular response to parathyroid hormone stimulus
Knockout
CRISPR knockout can remove candidate genes such as PTH1R or LRP5 to test whether they are required for the cellular response to PTH. This is the most direct way to establish necessity in a cell-autonomous process.
Point Mutation
Point-mutation models introduce specific amino acid changes to study how receptor variants alter PTH responsiveness. They are useful when a disease-associated allele is suspected to change signaling rather than abolish protein expression.
Knock-in
Knock-in of tags or reporter sequences allows visualization and quantification of proteins such as the calcium-sensing receptor during PTH response. This helps localize the molecular machinery within target cells.
Overexpression
Overexpression models test whether increasing the level of a candidate gene is sufficient to enhance or reprogram the cellular response to PTH. They complement knockout studies by addressing sufficiency rather than necessity.
How EDITGENE Supports cellular response to parathyroid hormone stimulus Research
Researchers studying cellular response to parathyroid hormone stimulus-related genes often need to determine whether a candidate gene is causally involved in the response or merely correlated with it. CRISPR-based perturbation provides a rigorous way to test necessity and sufficiency in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for cellular response to parathyroid hormone stimulus research.
Frequently Asked Questions About cellular response to parathyroid hormone stimulus
What is GO:0071374?
GO:0071374 is the Gene Ontology term for cellular response to parathyroid hormone stimulus, defined as any process that changes a cell's state or activity as a result of a parathyroid hormone stimulus.
What does cellular response to parathyroid hormone stimulus mean?
It means the set of changes inside a cell, such as movement, secretion, enzyme production or gene expression, that occur after the cell encounters parathyroid hormone.
What genes are involved in cellular response to parathyroid hormone stimulus?
Genes include PTH, PTH1R, CASR and LRP5, which have been studied in the context of PTH signaling, calcium sensing and bone anabolic responses.
Which receptor mediates the cellular response to parathyroid hormone?
The type 1 parathyroid hormone receptor (PTH1R) is a key mediator, and its conformation can be altered by mechanical stimuli in bone cells.
How is the cellular response to PTH regulated by calcium?
Extracellular calcium and the calcium-sensing receptor modulate PTH secretion and target-cell sensitivity, setting the responsiveness of the cellular response.
Can resistance to PTH action be reversed?
Yes, reversible resistance to the renal action of parathyroid hormone has been described in humans.
Is LRP5 required for the anabolic bone response to PTH?
LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
What research methods are used to study GO:0071374?
Methods include RNA-seq, receptor conformation assays, calcium-sensing assays, secretion assays, enzyme activity assays and CRISPR-based perturbation.
How do CRISPR models help study the cellular response to PTH?
CRISPR knockout, point mutation, knock-in and overexpression allow causal testing of whether a gene is required or sufficient for the response.
Why is GO:0071374 important for disease research?
It connects PTH action to calcium homeostasis, bone remodeling and clinical states such as PTH resistance and osteoporosis therapy.
Conclusion
GO:0071374, cellular response to parathyroid hormone stimulus, provides a precise ontology framework for the cell-autonomous actions of PTH. It covers receptor engagement, calcium-dependent set-point modulation and downstream changes in secretion, enzyme production and gene expression. Experimental evidence shows that this response is tunable, reversible and partly independent of mechanotransduction pathways such as LRP5. For researchers, the term is a practical guide for annotating genes and designing perturbation experiments. CRISPR knockout, point-mutation, knock-in and overexpression models, combined with transcriptomic and signaling assays, allow rigorous causal testing of candidate genes within this process.
References
- 1. Boden SD et al.. 1990. Calcium homeostasis.. Orthop Clin North Am 21(1):31-42 PMID: 2404236
- 2. Iamartino L et al.. 2022. The calcium-sensing receptor in inflammation: Recent updates.. Front Physiol 13:1059369 PMID: 36467702
- 3. Tomlinson S et al.. 1976. Reversible resistance to the renal action of parathyroid hormone in man.. Clin Sci Mol Med 51(1):59-69 PMID: 181194
- 4. Gasser JA et al.. 2000. PTH and interactions with bisphosphonates.. J Musculoskelet Neuronal Interact 1(1):53-6 PMID: 15758526
- 5. Sun F et al.. 1993. Heterogeneous response to calcium by individual parathyroid cells.. J Clin Invest 91(2):595-601 PMID: 8381822
- 6. Zhang YL et al.. 2009. Mechanical stimulus alters conformation of type 1 parathyroid hormone receptor in bone cells.. Am J Physiol Cell Physiol 296(6):C1391-9 PMID: 19369447
- 7. Orwoll E et al.. 1986. Acute parathyroid hormone secretory dynamics: hormone secretion from normal primate and adenomatous human tissue in response to changes in extracellular calcium concentration.. J Clin Endocrinol Metab 62(5):950-5 PMID: 3958130
- 8. Sawakami K et al.. 2006. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.. J Biol Chem 281(33):23698-711 PMID: 16790443
